Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
Neoadjuvant or Perioperative Approach in Lung Cancer.
Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
Howard, Frederick
Predicting response of molecular targeted therapies: a still possible challenge?
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Predicting response of molecular targeted therapies: a still possible challenge?
Predicting response of molecular targeted therapies: a still possible challenge? Ann Oncol. 2008 May; 19(5):829-30.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Cetuximab
Clinical Trials as Topic
Colorectal Neoplasms
Drug Delivery Systems
ErbB Receptors
Forecasting
Genes, erbB-1
Humans
Lung Neoplasms
Neoplasm Proteins
Patient Selection
Treatment Outcome
authors with profiles
Marina Chiara Garassino